| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2726200 | The American Journal of Medicine | 2006 | 10 Pages |
Abstract
NSAID+PPI affords greater risk reduction for dyspepsia than Coxibs when compared with the common baseline of NSAIDs. Because there are limited head-to-head data comparing Coxibs versus NSAID+PPI, these data provide the best indirect evidence that NSAID+PPI may be superior to Coxibs in minimizing incident dyspepsia.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Brennan M.R. MD, MSHS, Mary DO, Gareth S. MD, MSHS, Ian M. MD, MSHS, Fasiha MD, MSHS,